| 标题 |
[求助补充材料]
Domvanalimab combined with zimberelimab as first-line treatment in patients with PD-L1–high, advanced non-small cell lung cancer: Results from the randomized phase 2 ARC-10 study, Part 1 |
| 备注 |
仅需ARC-10 Part1本文官方Supplementary material(mmc1.pdf,约1.89 MB),含随附方案/SAP如有。 正文已有,无需正文。DOI 10.1016/j.lungcan.2026.109316。
💡 该求助存在备注,如果存在信息冲突,请以备注为准
|
| 网址 | |
| DOI | |
| 求助人 | |
| 下载 | 该求助完结已超 24 小时,文件已从服务器自动删除,无法下载。 |
PDF的下载单位、IP信息已删除
(2025-6-4)